Modulation of oestrone sulphatase activity in breast cancer cell lines by growth factors
- 1 March 1992
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 41 (3-8) , 563-566
- https://doi.org/10.1016/0960-0760(92)90384-u
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- INSULIN-LIKE GROWTH FACTOR TYPE I AND INSULIN-LIKE GROWTH FACTOR TYPE II STIMULATE OESTRADIOL-17β HYDROXYSTEROID DEHYDROGENASE (REDUCTIVE) ACTIVITY IN BREAST CANCER CELLSJournal of Endocrinology, 1991
- Importance of estrogen sulfates in breast cancerJournal of Steroid Biochemistry, 1989
- Aromatase activity in normal breast and breast tumor tissues: In vivo and in vitro studiesSteroids, 1987
- The effect of epidermal growth factor, transforming growth factor and breast tumour homogenates on the activity of oestradiol 17β hydroxysteroid dehydrogenase in cultured adipose tissueCancer Letters, 1986
- In Situ Estrogen Production via the Estrone Sulfatase Pathway in Breast Tumors: Relative Importance versus the Aromatase Pathway*Journal of Clinical Endocrinology & Metabolism, 1984
- THE RELATIONSHIP BETWEEN 17β‐HYDROXYSTEROID DEHYDROGENASE ACTIVITY AND OESTROGEN CONCENTRATIONS IN HUMAN BREAST TUMOURS AND IN NORMAL BREAST TISSUEClinical Endocrinology, 1983
- The plasma concentration of oestrone sulphate in postmenopausal women: Lack of diurnal variation, effect of ovariectomy, age and weightJournal of Steroid Biochemistry, 1981